2021
DOI: 10.1016/j.biomaterials.2020.120556
|View full text |Cite
|
Sign up to set email alerts
|

Biosynthetic, biomimetic, and self-assembled vascularized Organ-on-a-Chip systems

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
41
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 40 publications
(41 citation statements)
references
References 158 publications
0
41
0
Order By: Relevance
“…Similarly, there is increasing investigation using artificially assembled microfluidic approaches that enable the cocultivation with capillary-like structures, as well as exposure to immune cells, with the advantage of also presenting exposure to “blood” flow. 111 , 112 To date, there are reports of airway microfluidic cultures, cocultivated with vascular and immune cells, for posterior exposure to pathogens, including SARS-CoV-2. 38 , 102 − 104 The microfluidic upside is that the blood-like tissue is pumped throughout the culture system, using a fluid flow, simulating the in vivo situation.…”
Section: Airway and Lung Organoid Modelsmentioning
confidence: 99%
See 1 more Smart Citation
“…Similarly, there is increasing investigation using artificially assembled microfluidic approaches that enable the cocultivation with capillary-like structures, as well as exposure to immune cells, with the advantage of also presenting exposure to “blood” flow. 111 , 112 To date, there are reports of airway microfluidic cultures, cocultivated with vascular and immune cells, for posterior exposure to pathogens, including SARS-CoV-2. 38 , 102 − 104 The microfluidic upside is that the blood-like tissue is pumped throughout the culture system, using a fluid flow, simulating the in vivo situation.…”
Section: Airway and Lung Organoid Modelsmentioning
confidence: 99%
“… 38 , 102 − 104 The microfluidic upside is that the blood-like tissue is pumped throughout the culture system, using a fluid flow, simulating the in vivo situation. 111 , 112 There are reports of the establishment of distal airway microfluidic models, or specifically alveolar cultures, cocultivated with microvasculature 102 , 104 and immune cells 102 − 104 on a chip, for further SARS-CoV-2 exposure and investigation. The results indicate the important involvement of immune responses through the alveolar barrier, showing that the microfluidic system resembles in vivo situations and could be valid for research that requires interaction to blood and immune cells.…”
Section: Airway and Lung Organoid Modelsmentioning
confidence: 99%
“…Bio-inspired or biomimetic design of biomaterials presents new possibilities for developing implantable devices with enhanced biocompatibility and novel functions [1][2][3][4][5][6][7][8]. No study has yet reported a potential application of biomimetic surface morphology, particularly at the nano-level, to endosseous implants for commercial use in the fields of dental and orthopedic surgery [9][10][11][12][13][14][15][16][17][18][19][20].…”
Section: Introductionmentioning
confidence: 99%
“…While polydimethylsiloxane (PDMS) is the most commonly preferred material due to its high biocompatibility, transparency, and oxygen permeability, high level adsorption of proteins on the surface of PDMS have been reported by multiple studies, which results in the given drug or stimulating substance to not to fully interact with the cells within the chip [88]. In addition, the interaction between the cells and ECM is crucial for organ function as well as pathogen colonization; however, synthetic biomaterials usually possess mechanical properties different to native ECM [89]. While patient-specificity is a remarkable aspect of organ chips, patient tissue cells are usually limited in number or exhibit low proliferation, and their collection may require invasive techniques.…”
Section: Limitationsmentioning
confidence: 99%